Menopause Recruiting Phase 2 Trials for Testosterone (DB00624)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02445716Transdermal Testosterone Nanoemulsion in Women LibidoTreatment